RACHEL COLLINS: Open Payments
NPI 1255746095 · GREELEY, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,440 in 119 payments from 18 companies in 2025. Trend: 2023 $2,226 · 2024 $2,663 · 2025 $3,440
Food & beverage: $3,285Education: $155
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 13 | $472 |
| GENZYME CORPORATION | 8 | $415 |
| Arcutis Biotherapeutics, Inc. | 14 | $386 |
| ABBVIE INC. | 20 | $340 |
| Janssen Biotech, Inc. | 12 | $338 |
| Organon LLC | 8 | $313 |
| Amgen Inc. | 6 | $245 |
| PFIZER INC. | 11 | $224 |
| E.R. Squibb & Sons, L.L.C. | 9 | $204 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $138 |
Products named: DUPIXENT, NEMLUVIO, Zoryve, TREMFYA, VTAMA, SKYRIZI, OTEZLA, CIBINQO.
Industry payments across CO — which companies pay providers there.
